Table 2: eGFR, creatinine and potassium
levels before and after 7 days of L-AMB treatment in all attacks and in attacks
where nephrotoxicity developed.
|
All attacks (n=62) |
|||
|
|
Before L-AMB treatment |
After 7 days of L-AMB treatment |
P |
|
eGFR (ml/min/1,73m2) |
198.7 (165-263.3) |
189 (148-237) |
0.14 |
|
Creatinine (mg/dl) |
0.32 (0.23-0.43) |
0.37 (0.24-0.49) |
0.074 |
|
Potassium (mmol/L) |
4.04±0.61 |
3.64 ±0.65 |
<0.001 |
|
|
Attacks with nephrotoxicity (n=16) |
|
|
|
eGFR (ml/min/1,73m2) |
308.5 (230.70-340.40) |
165.5 (94.90-196.20) |
<0.001 |
|
Creatinine (mg/dl) |
0.23 (0.17-0.32) |
0.49 (0.27-0.67) |
<0.001 |
|
Potassium (mmol/L) |
4.12±0.56 |
3.77±0.68 |
>0.05 |
eGFR:
Estimated glomerular filtration rate.